391 related articles for article (PubMed ID: 17681647)
1. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response.
Hansen B; Sokolovska A; HogenEsch H; Hem SL
Vaccine; 2007 Sep; 25(36):6618-24. PubMed ID: 17681647
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
[TBL] [Abstract][Full Text] [Related]
3. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.
Hansen B; Belfast M; Soung G; Song L; Egan PM; Capen R; Hogenesch H; Mancinelli R; Hem SL
Vaccine; 2009 Feb; 27(6):888-92. PubMed ID: 19071182
[TBL] [Abstract][Full Text] [Related]
4. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production.
Iyer S; HogenEsch H; Hem SL
Vaccine; 2003 Mar; 21(11-12):1219-23. PubMed ID: 12559801
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.
Iyer S; Robinett RS; HogenEsch H; Hem SL
Vaccine; 2004 Mar; 22(11-12):1475-9. PubMed ID: 15063571
[TBL] [Abstract][Full Text] [Related]
7. Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid.
Morefield GL; Jiang D; Romero-Mendez IZ; Geahlen RL; Hogenesch H; Hem SL
Vaccine; 2005 Feb; 23(12):1502-6. PubMed ID: 15670886
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.
Noe SM; Green MA; HogenEsch H; Hem SL
Vaccine; 2010 Apr; 28(20):3588-94. PubMed ID: 20211692
[TBL] [Abstract][Full Text] [Related]
9. Effect of the strength of adsorption of HIV 1 SF162dV2gp140 to aluminum-containing adjuvants on the immune response.
Hansen B; Malyala P; Singh M; Sun Y; Srivastava I; Hogenesch H; Hem SL
J Pharm Sci; 2011 Aug; 100(8):3245-3250. PubMed ID: 21425166
[TBL] [Abstract][Full Text] [Related]
10. Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid.
Jiang D; Morefield GL; HogenEsch H; Hem SL
Vaccine; 2006 Mar; 24(10):1665-9. PubMed ID: 16246468
[TBL] [Abstract][Full Text] [Related]
11. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
Hem SL; Hogenesch H
Expert Rev Vaccines; 2007 Oct; 6(5):685-98. PubMed ID: 17931150
[TBL] [Abstract][Full Text] [Related]
12. Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins.
Iyer S; HogenEsch H; Hem SL
Pharm Dev Technol; 2003; 8(1):81-6. PubMed ID: 12665200
[TBL] [Abstract][Full Text] [Related]
13. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity.
Capelle MA; Brügger P; Arvinte T
Vaccine; 2005 Feb; 23(14):1686-94. PubMed ID: 15705473
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant.
Levesque PM; de Alwis U
Hum Vaccin; 2005; 1(2):70-3. PubMed ID: 17038824
[TBL] [Abstract][Full Text] [Related]
15. Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker.
Lu F; Boutselis I; Borch RF; Hogenesch H
Vaccine; 2013 Sep; 31(40):4362-7. PubMed ID: 23887038
[TBL] [Abstract][Full Text] [Related]
16. Distribution of adsorbed antigen in mono-valent and combination vaccines.
Morefield GL; HogenEsch H; Robinson JP; Hem SL
Vaccine; 2004 May; 22(15-16):1973-84. PubMed ID: 15121310
[TBL] [Abstract][Full Text] [Related]
17. Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.
DePaz RA; Henderson I; Advant SJ
Vaccine; 2005 Jul; 23(31):4029-35. PubMed ID: 15963360
[TBL] [Abstract][Full Text] [Related]
18. Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.
Beck Z; Torres OB; Matyas GR; Lanar DE; Alving CR
J Control Release; 2018 Apr; 275():12-19. PubMed ID: 29432824
[TBL] [Abstract][Full Text] [Related]
19. Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen.
Wittayanukulluk A; Jiang D; Regnier FE; Hem SL
Vaccine; 2004 Mar; 22(9-10):1172-6. PubMed ID: 15003645
[TBL] [Abstract][Full Text] [Related]
20. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
